Bisantrene in non-small cell lung cancer: a phase II trial of the Cancer and Leukemia Group B

Cancer Treat Rep. 1986 Apr;70(4):539-40.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anthracenes / adverse effects
  • Anthracenes / therapeutic use
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use*
  • Drug Evaluation
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology
  • Male
  • Middle Aged
  • Time Factors

Substances

  • Anthracenes
  • Antibiotics, Antineoplastic
  • bisantrene